BVF INVESTMENTS LLC
CIK 1132245 · last filed 2015-11-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
CRA price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
30TH FL
SAN FRANCISCO, CA 94104
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CCXI | 2,744,577 | $10.25 | $28.13M | -$50.09M | 3 | 2015-11-02 | |
| CBIO | 16,323 | $12.76 | $208.3K | $0 | 1 | 2015-08-21 | |
| LGND | 248,144 | $308.30 | $76.50M | $7.41M | 3 | 2014-03-26 | |
| RIGL | 112,385 | $49.91 | $5.61M | -$7.68M | 1 | 2013-11-20 | |
| Celera CORP (CRA) Delisted | 34,656,684 | — | — | $204.30M | 2 | 2011-05-12 | |
| NBIX | 10,257,894 | $145.87 | $1.50B | -$2.39M | 3 | 2010-04-13 | |
| FACT | 7,671,129 | $10.76 | $82.54M | $40.31M | 2 | 2010-02-04 | |
| NEUROBIOLOGICAL TECHNOLOGIES INC /CA/ (NTII) Delisted | 4,133,897 | — | — | -$25.15M | 1 | 2009-10-23 | |
| AVIGEN INC \DE (AVGN) Delisted | 15,952,630 | — | — | -$3.03M | 3 | 2009-10-23 | |
| EPIRUS Biopharmaceuticals, Inc. (CRXX) Delisted | 8,404,399 | — | — | $56.2K | 2 | 2008-11-26 |
Recent Filings · Page 2 of 3
24 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2010-04-13 | NBIX | Sell (S) | −1,188,000 | -$3.30M | EDGAR |
| 2010-04-02 | — | Sell (S) | −22,518,000 | -$137.66M | |
| 2010-02-04 | FACT | Buy (P) | +940,494 | $14.74M | EDGAR |
| 2010-01-29 | FACT | Buy (P) | +1,629,600 | $25.57M | EDGAR |
| 2009-10-23 | NEUROBIOLOGICAL TECHNOLOGIES INC /CA/ (NTII) Delisted | Sell (S) | −27,638,370 | -$25.15M | EDGAR |
| 2009-10-23 | AVIGEN INC \DE (AVGN) Delisted | Sell (S) | −2,833,200 | -$4.25M | EDGAR |
| 2009-10-20 | — | Sell (S) | −3,830,400 | -$90.38M | |
| 2009-01-26 | NBIX | Buy (P) | +79,500 | $246.3K | EDGAR |
| 2008-11-26 | EPIRUS Biopharmaceuticals, Inc. (CRXX) Delisted | Buy (P) | +61,500 | $28.8K | EDGAR |
| 2008-11-26 | NBIX | Buy (P) | +272,000 | $666.3K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.